Earlier this month Sarepta announced a change in leadership, with CMO Ed Kaye taking over as interim CEO. Following that announcement the team at Sarepta organized a call with Duchenne patient organizations and foundations to update them on the transition. The messages were very clear from the call: Everything is still moving forward - they are all about continuity. There is a renewed passion…